MedPath

Sacrosidase

Generic Name
Sacrosidase
Brand Names
Sucraid
Drug Type
Biotech
CAS Number
85897-35-4
Unique Ingredient Identifier
8A7F670F2Y

Overview

Sacrosidase is a liquid enzyme preparation from S.cerevisiae used for the treatment of congenital sucrose-isomaltase deficiency (CSID). People with CSID have variable amounts of sucrose-isomaltase enzyme activity and therefore have issues metabolizing dietary disaccharide sucrose causing chronic or intermittent watery diarrhea in infants and children. Treatment options for these patients are limited and usually consists of a lifelong sucrose-free diet; therefore, sacrosidase offers a potential alternative for symptom relief.

Background

Sacrosidase is a liquid enzyme preparation from S.cerevisiae used for the treatment of congenital sucrose-isomaltase deficiency (CSID). People with CSID have variable amounts of sucrose-isomaltase enzyme activity and therefore have issues metabolizing dietary disaccharide sucrose causing chronic or intermittent watery diarrhea in infants and children. Treatment options for these patients are limited and usually consists of a lifelong sucrose-free diet; therefore, sacrosidase offers a potential alternative for symptom relief.

Indication

For the treatment of congenital sucrose-isomaltase deficiency (CSID).

Associated Conditions

  • Sucrase-isomaltase deficiency

FDA Approved Products

Sucraid
Manufacturer:QOL Medical, LLC
Route:ORAL
Strength:8500 [iU] in 1 mL
Approved: 2023/12/15
NDC:67871-111

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath